![Herbert Cross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Herbert Cross
Directeur Financier/CFO chez
JASPER THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Herbert C.
Cross is currently Director at DNAtrix, Inc. since 2021 and Secretary, Chief Financial & Accounting Officer at Jasper Therapeutics, Inc. since 2023.
Formerly, served as Independent Director at Apexigen, Inc. and Apexigen America, Inc. from 2019 to 2023.
Served as Chief Financial Officer at Atreca, Inc. from 2019 to 2023.
Held the position of Chief Financial & Accounting Officer at ARMO Biosciences, Inc. from 2017 to 2018.
Was Chief Financial Officer at Balance Therapeutics, Inc. from 2016 to 2017.
Held the role of Chief Executive & Financial Officer at Humanigen, Inc. in 2015.
Served as Chief Financial Officer at Affymax, Inc. from 2011 to 2013.
Was Principal Accounting Officer & Controller at Abbott Biotherapeutics Corp.
from 2008 to 2014.
Held the position of Chief Accounting Officer at PDL BioPharma, Inc. from 2006 to 2009.
Served as Vice President-Finance at Neoforma, Inc. from 2001 to 2007.
Worked as Manager-Assurance & Business Advisory Services at Arthur Andersen LLP in 1999.
Education includes undergraduate degree from Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Herbert Cross
| Sociétés | Poste | Début |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Directeur Financier/CFO | 22/09/2023 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Directeur/Membre du Conseil | 18/02/2021 |
Anciens postes connus de Herbert Cross
| Sociétés | Poste | Fin |
|---|---|---|
| ATRECA, INC. | Directeur Financier/CFO | 22/09/2023 |
| APEXIGEN, INC. | Directeur/Membre du Conseil | 23/08/2023 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Directeur/Membre du Conseil | 01/08/2023 |
| ARMO BIOSCIENCES INC | Directeur Financier/CFO | 21/06/2018 |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disabilities | Directeur Financier/CFO | 01/11/2017 |
Formation de Herbert Cross
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Neoforma, Inc.
 Neoforma, Inc. Medical DistributorsDistribution Services Provides e-commerce services to healthcare industry | Distribution Services |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disabilities | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
